(Q46613245)

23 December 2017

title

Conversion therapy to everolimus in renal transplant recipients: results after one year (English)

1 reference

23 December 2017

author name string

F Giron

1

1 reference

23 December 2017

Y Baez

2

1 reference

23 December 2017

A Niño-Murcia

3

1 reference

23 December 2017

J Rodríguez

4

1 reference

23 December 2017

S Salcedo

5

1 reference

23 December 2017

language of work or name

English

0 references

publication date

1 April 2008

1 reference

23 December 2017

Transplantation Proceedings

published in

1 reference

23 December 2017

volume

40

1 reference

23 December 2017

issue

3

1 reference

23 December 2017

page(s)

711-713

1 reference

23 December 2017

Everolimus: a review of its use in renal and cardiac transplantation

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2008.03.012

Conversion to everolimus in maintenance patients--current clinical strategies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2008.03.012

Improved graft survival after renal transplantation in the United States, 1988 to 1996

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2008.03.012

Conversion from a calcineurin inhibitor-based immunosuppressive regimen to everolimus in renal transplant recipients: effect on renal function and proteinuria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2008.03.012

Everolimus with optimized cyclosporine dosing in renal transplant recipients: 6-month safety and efficacy results of two randomized studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2008.03.012

Target of rapamycin inhibitors (sirolimus and everolimus) for primary immunosuppression of kidney transplant recipients: a systematic review and meta-analysis of randomized trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2008.03.012

Introducing everolimus (Certican) in organ transplantation: an overview of preclinical and early clinical developments

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2008.03.012

Calcineurin inhibitor withdrawal from sirolimus-based therapy in kidney transplantation: a systematic review of randomized trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2008.03.012

10.1016/J.TRANSPROCEED.2008.03.012

7 January 2021

Identifiers

DOI

1 reference

23 December 2017

1 reference

23 December 2017